Top Story

New next-generation sequencing test launched for thyroid nodules

December 20, 2014

Interpace Diagnostics, a molecular diagnostics subsidiary of PDI, Inc., has recently launched a new next-generation sequencing test designed to determine the difference between benign and malignant genotypes of thyroid nodules, according to a release from the company.

The test, ThyGenX, can be used to help physicians reduce unnecessary surgery. Eight genes associated with papillary and follicular carcinoma make up the panel of genes tested.

In the Journals

Nonenhanced neck CT may detect diffuse thyroid disease

December 19, 2014
Nonenhanced CT images are effective for differentiating diffuse thyroid disease from normal thyroid, according to recent findings published in the International Journal
In the Journals

More studies urged in managing posttreatment fatigue in thyroid cancer

December 17, 2014
A paucity of reliable trials exists to guide evidence-based management of posttreatment fatigue in thyroid cancer survivors, according to a systematic review published…
In the Journals

Improved outcomes in HNSCC may be due to HPV incidence

December 5, 2014
Survival for patients with oropharyngeal head and neck squamous cell cancer improved significantly between 1993 and 2010, according to study results.However, outcomes…
CME
Hot melanoma

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video
thumbnail for video 3886443649001

Risk stratification guidelines help determine treatment for thyroid cancer

November 11, 2014
Fabian Pitoia, MD,  head of the thyroid section of the division of endocrinology at the Hospital de Clinicas of…
More »
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »

New next-generation sequencing test launched for thyroid nodules

December 20, 2014
Interpace Diagnostics, a molecular diagnostics subsidiary of PDI, Inc., has recently launched a new next-generation sequencing test designed to…
In the Journals

Nonenhanced neck CT may detect diffuse thyroid disease

December 19, 2014
Nonenhanced CT images are effective for differentiating diffuse thyroid disease from normal thyroid, according to recent findings published in the…
In the Journals

More studies urged in managing posttreatment fatigue in thyroid cancer

December 17, 2014
A paucity of reliable trials exists to guide evidence-based management of posttreatment fatigue in thyroid cancer survivors, according to a…
In the Journals

Improved outcomes in HNSCC may be due to HPV incidence

December 5, 2014
Survival for patients with oropharyngeal head and neck squamous cell cancer improved significantly between 1993 and 2010, according to study…
Sally E. Carty, MD In the Journals

High radioactive iodine-131 exposure dose linked to aggressive thyroid cancer

December 2, 2014
Children and adolescents exposed to high doses of radioactive iodine-131 after the Chernobyl nuclear power plant accident experienced greater rates…
Association News

American Thyroid Association elects board members

November 28, 2014
The American Thyroid Association installed new board members during its 84th annual meeting in Coronado, Calif.Robert C. Smallridge, MD, will…
In the Journals

Upfront laryngectomy may improve survival in advanced-stage laryngeal cancer

November 27, 2014
A single academic center that frequently performed surgical therapy for patients with advanced-stage laryngeal cancer reported a higher rate of…
In the Journals

Researchers identify factors associated with hypocalcemia after thyroidectomy

November 25, 2014
A low postoperative intact parathyroid hormone level, female gender and presence of malignant neoplasm all independently predicted hypocalcemia after…
thumbnail for video 3890508474001 Meeting News CoverageVideo

Lenvatinib, sorafenib may significantly impact treatment of differentiated thyroid cancer

November 13, 2014
Marcia S. Brose, MD, PhD, associate professor at the University of Pennsylvania and director of the thyroid cancer therapeutics program and of the…
In the Journals

BRAF V600E mutation increased recurrence risk in papillary thyroid cancer

November 12, 2014
Presence of a BRAF V600E mutation appeared to predict recurrence in patients treated for papillary thyroid cancer, according to results of a…
More Headlines »
morganatic-roan
morganatic-roan